Miscellaneous Equine Liver Conditions.

This article outlines several uncommon equine liver disorders, explaining what they are, how they present, and how they are managed. Some conditions are acute and often fatal (notably Tyzzer’s disease in foals), while others are chronic but treatable or even benign with supportive care.

Scope and clinical relevance

• Focuses on five liver conditions not covered elsewhere: chronic active hepatitis, Tyzzer’s disease, seasonal idiopathic hepatitis, primary hepatic neoplasia, and idiopathic persistent hyperbilirubinemia.
• Emphasizes practical differences in cause, typical signalment, diagnostic approach, treatment options, and prognosis to guide case triage and client communication.

Chronic active hepatitis (CAH)

• Definition and pathogenesis
  • Inflammatory and fibrotic liver disease of unknown cause in horses, analogous to chronic hepatitis in other species.
  • Suspected contributors include prior infectious insult, toxins, or immune-mediated mechanisms that perpetuate inflammation and fibrosis.
• Clinical presentation
  • Chronic weight loss, poor performance, intermittent fever, lethargy, anorexia.
  • Icterus and photosensitization may occur; in advanced cases, signs of hepatic encephalopathy (behavior change, head pressing) can develop.
• Diagnostics
  • Serum chemistry: persistent increases in liver enzymes (e.g., GGT, AST, GLDH/SDH), hyperbilirubinemia; elevated bile acids suggest functional impairment.
  • Ultrasound may reveal an irregular, hyperechoic or heterogenous liver; sampling guided by imaging increases safety.
  • Liver biopsy is the diagnostic standard to confirm chronic inflammation and fibrosis and to stage severity.
  • Exclude infectious, toxic, and metabolic differentials where possible.
• Treatment
  • Goal is to reduce inflammation and slow fibrosis progression.
  • Anti-inflammatory and immunomodulatory therapy (e.g., corticosteroids) used judiciously after ruling out active sepsis; adjuncts such as pentoxifylline and antioxidants (e.g., vitamin E, S-adenosylmethionine) are sometimes employed.
  • Nutritional support: frequent small meals, adequate energy, balanced protein; manage encephalopathy with dietary protein moderation and lactulose if indicated.
  • Supportive care: maintain hydration, control pruritus/photosensitization, avoid hepatotoxic drugs.
• Prognosis and monitoring
  • Variable; depends on fibrosis extent and response to therapy.
  • Monitor serial liver enzymes, bile acids, clinical status; adjust therapy based on trends.

Tyzzer’s disease

• Etiology and epidemiology
  • Caused by Clostridium piliforme, an obligate intracellular, spore-forming bacterium.
  • Classically affects very young foals (often 1–6 weeks old); spores persist in the environment, and disease is often peracute.
• Pathology and clinical signs
  • Acute, multifocal, necrotizing hepatitis with high case fatality.
  • Peracute depression, fever, recumbency, seizures, diarrhea; profound hypoglycemia is common.
• Diagnostics
  • Clinicopathology may show severe hypoglycemia, metabolic acidosis, leukopenia or leukocytosis, markedly elevated liver enzymes and bilirubin.
  • Definitive diagnosis often postmortem (histology with silver stains or PCR on tissues); antemortem diagnosis is challenging due to rapid course.
• Treatment and outcome
  • Aggressive supportive care (IV dextrose, fluids, plasma, management of seizures) and early antimicrobial therapy targeting C. piliforme (e.g., tetracycline-class agents) are indicated.
  • Despite intervention, successful treatment is rare; prognosis is grave.
• Prevention
  • Meticulous foaling-area hygiene, good colostrum management, minimizing overcrowding and stress.
  • No vaccine is available; environmental control and early recognition are key.

Seasonal idiopathic hepatitis

• Overview
  • Described as a winter-season hepatopathy of Midwestern horses with unknown cause.
  • Tends to have a favorable natural course with appropriate supportive care.
• Clinical picture
  • Lethargy, reduced appetite, and icterus are typical; many cases are mild to moderate.
  • Coagulopathy and severe encephalopathy are uncommon compared with fulminant hepatic failure syndromes.
• Diagnostics
  • Serum chemistry: hyperbilirubinemia with variable increases in liver enzymes; bile acids may be elevated.
  • Rule out infectious and toxic hepatopathies; imaging and, in select cases, biopsy can help if the course is atypical.
• Management and prognosis
  • Supportive care: palatable high-quality feed, consistent access to water, careful use of NSAIDs, antioxidants, and avoidance of potential hepatotoxins.
  • Most horses recover fully; prognosis is excellent when complications are absent.

Primary hepatic neoplasia

• Types and frequency
  • Rare in horses; primary tumors include hepatocellular carcinoma, cholangiocarcinoma, and mixed hepatobiliary tumors.
  • Lymphoma commonly involves the liver but is typically secondary/multicentric rather than primary hepatic neoplasia.
• Clinical signs
  • Chronic weight loss, intermittent fever, inappetence, icterus; possible colic or abdominal distension if masses are large.
• Diagnostics
  • Persistent enzyme elevations and hyperbilirubinemia; anemia or paraneoplastic changes may be present.
  • Ultrasound identifies mass lesions; definitive diagnosis requires cytology/histopathology via FNA or biopsy (with attention to hemorrhage risk).
• Treatment and prognosis
  • Curative options are limited; surgical resection is rarely feasible due to lesion size/location.
  • Management is usually palliative/supportive; overall prognosis is guarded to poor, depending on tumor type and extent.

Idiopathic persistent hyperbilirubinemia

• Nature of the condition
  • Uncommon, benign elevation of bilirubin (often predominantly unconjugated) without evidence of hepatocellular injury or cholestasis.
  • Distinct from common, transient fasting-associated hyperbilirubinemia in horses.
• Diagnosis
  • Diagnosis of exclusion: normal liver enzymes and bile acids, no hemolysis, and persistent bilirubin elevation in an otherwise healthy horse.
  • Monitoring over time confirms stability without progression to hepatic disease.
• Management and outlook
  • No specific treatment required; avoid unnecessary interventions.
  • Prognosis is excellent; educate owners to prevent alarm with incidental lab findings.

Clinical differentiation at a glance

• Foal, peracute collapse/seizures, severe hypoglycemia → strongly suspect Tyzzer’s disease; initiate aggressive supportive care and tetracycline-class antibiotics, though prognosis is poor.
• Adult horse, chronic weight loss and enzyme elevations → consider chronic active hepatitis; confirm with biopsy and treat to reduce inflammation/fibrosis.
• Adult horses in winter with mild-moderate icterus and lethargy, often clustered regionally → seasonal idiopathic hepatitis; supportive care usually suffices.
• Older horse with focal liver masses on imaging → primary hepatic neoplasia likely; pursue cytology/histopathology; prognosis guarded.
• Healthy horse with isolated, persistent bilirubin elevation but normal enzymes/bile acids → idiopathic persistent hyperbilirubinemia; no treatment needed.

Key takeaways

• Not all hyperbilirubinemia signals liver failure; context and accompanying lab changes matter.
• Biopsy remains central for staging chronic inflammatory liver disease and guiding therapy.
• Tyzzer’s disease progresses too rapidly for definitive antemortem confirmation in many cases; early, aggressive care is essential but survival is uncommon.
• Supportive care is the backbone for many equine hepatopathies and can be curative in seasonal idiopathic hepatitis and unnecessary in benign hyperbilirubinemia.
• Primary hepatic tumors are rare but should be suspected with focal lesions and chronic wasting in older horses; manage expectations regarding prognosis.